Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rifadin Capsules 300mg*


Contraindicated
Risk of maternal and neonatal hemorrhage

Contraindicated
Rifadin Capsules 300mg* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Gruppo Lepetit SRL
Origin Italy
Manufacturer Gruppo Lepetit
Origin Italy
ATC J04AB02

Your comment will appear shortly after approval

Rifadin Capsules 300mg* :

Revision Date : 05/01/2018


Effect Frequency
Abdominal bloating (Meteorism) Not known
Abdominal pain Not known
Agranulocytosis Not known
ALT increased Common
Anaphylactic reactions Not known
Anaphylactic shock Not known
AST increased Common
Blood bilirubin increased Common
Blood creatinine increased Not known
Blood pressure increased Not known
Bone pain Not known
Chromaturia Not known
Color changes of teeth Not known
Decreased appetite Not known
Dermatitis allergic Not known
Diarrhoea (Diarrhea) Uncommon
Disseminated intravascular coagulation Not known
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Dyspnoea (dyspnea) Not known
Eosinophilia Not known
Erythema multiforme Not known
Fetal-maternal hemorrhage Not known
Flu Syndrome Not known
Haemolytic anemia Not known
Hepatic enzyme increased Not known
Hepatitis Not known
Hyperbilirubinaemia Not known
Hypereosinophilia Not known
Hypersensitivity reactions Not known
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Menstrual disorder Not known
Muscle weakness Not known
Myopathy Not known
Nausea Common
Oedema Not known
Phlegm discoloured Not known
Porphyria Not known
Postpartum hemorrhage Not known
Pruritus Not known
Pseudomembranous colitis Not known
Psychiatric disorders Not known
Purpura Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Not known
Renal tubular necrosis Not known
Respiratory disorder Not known
Shock Not known
Stevens-Johnson syndrome Not known
Sweat discolouration Not known
Tear discoloration Not known
Thrombocytopenia (Thrombopenia) Common
Tubulointerstitial nephritis Not known
Urticaria Not known
Vasculitides Not known
Vomiting Common

Different Units By MoH Code

Revision Date : 01/05/2015

Rifadin Capsules 300mg* Rifadin Capsules 300mg* Rifadin Capsules 300mg* Rifadin Capsules 300mg* Rifadin Capsules 300mg* Rifadin Capsules 300mg*

Rifadin Capsules 300mg*  MoH 3084 :
Form Capsule, hard
Packaging Blisters
Package Size Box of 8
Strength 300mg
NSSF ✘
Quarantine ✘
Reg. Number 18479
Submission date 01/01/1969
Registration Year 1969
Archived Date 03/12/2020


Price Comparison

● Country: The Netherlands
● Package Size: 8
● Public Price: 12.31 EUR ( 1,192,543.56 LBP )
● Pack size unit used: 8
● Cost/Unit: 1,5388 EUR ( 96,876.00 LBP )
● Pharmacy Price: 5.31 EUR ( 514411.56 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 100
● Public Price: 209.5 AED ( 5,061,729.50 LBP )
● Pack size unit used: 100
● Cost/Unit: 2,095 AED ( 48,322.00 LBP )
● Pharmacy Price: 168.82 AED ( 4078860.02 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 100's
● Public Price: 209.5 AED ( 5,061,729.50 LBP )
● Pack size unit used: 100
● Cost/Unit: 2,095 AED ( 48,322.00 LBP )
● Pharmacy Price: 168.82 AED ( 4078860.02 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 8
● Public Price: 13 QAR ( 319,254.00 LBP )
● Pack size unit used: 8
● Cost/Unit: 1,625 QAR ( 24,558.00 LBP )
● Pharmacy Price: 10.7304255292 QAR ( 263517.79014609 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 8
● Public Price: 12.75 SAR ( 301,410.00 LBP )
● Pack size unit used: 8
● Cost/Unit: 1,5938 SAR ( 23,640.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 12
● Public Price: 4.82 EUR ( 466,942.32 LBP )
● Pack size unit used: 12
● Cost/Unit: 0,4017 EUR ( 0.00 LBP )
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019
● Type: Medicine Authorised

● Country: Italy
● Package Size: 8UNITA
● Public Price: 3.72 EUR ( 360,378.72 LBP )
● Pack size unit used: 8
● Cost/Unit: 0,465 EUR ( 0.00 LBP )
● Pricing Date: 15/01/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 100
● Public Price: 43.59 EUR ( 4,222,824.84 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,4359 EUR ( 0.00 LBP )
● Exfactory Price: 41 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 50
● Public Price: 31.24 EUR ( 3,026,406.24 LBP )
● Pack size unit used: 50
● Cost/Unit: 0,6248 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 8
● Public Price: 0.54 KWD ( 158,533.74 LBP )
● Pack size unit used: 8
● Cost/Unit: 0,0675 KWD ( 0.00 LBP )
● Pharmacy Price: 0.45 KWD ( 132111.45 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 16
● Public Price: 10.83 TRY ( 29,024.40 LBP )
● Pack size unit used: 16
● Cost/Unit: 0,6769 TRY ( 0.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 8
● Public Price: 2.24 JOD ( 280,495.04 LBP )
● Pack size unit used: 8
● Cost/Unit: 0,28 JOD ( 0.00 LBP )
● Pharmacy Price: 1.71 JOD ( 214127.91 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020
● Type: Medicine Authorised

● Country: UK
● Package Size: 100
● Public Price: 36.63 GBP ( 4,162,962.87 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,3663 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: France
● Form: Capsule, hard
● Package Size: 8
● Public Price: 5.65 EUR ( 547,349.40 LBP )
● Pack size unit used: 8
● Cost/Unit: 0,7062 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 8
● Public Price: 4.8 EUR ( 465,004.80 LBP )
● Pack size unit used: 8
● Cost/Unit: 0,6 EUR ( 0.00 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: New Zealand
● Package Size: 100 cap
● Exfactory Price: 116.25 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info